Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIFT: GM-CSF for Immunomodulation Following Trauma
NCT01495637Phase 4Completed
- Start
- Dec 2011
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of sargramostim. Started Dec 2011; status: completed.
02
Drugs
sargramostim
Beyond the preview
Go deeper on NCT01495637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495637.